I-REMOVE Brand Ambassadors Ride for Women’s Cancer Research

Salt Lake City, June 15, 2017 -- Zaluvida North America sponsored three I-REMOVE Brand Ambassadors to participate in the 30th Annual Little Red Riding Hood Bicycling event in Cache Valley, Utah. A portion of the proceeds from the event will benefit the Huntsman Cancer Institute, going towards breast and ovarian cancer research.

I-REMOVE Brand Ambassadors, Melissa Neil, Amy Johnson and Jenna Beesley ride for cancer research in Northern Utah.

“At Zaluvida, we strive to support positive changes,” said Vice President of Marketing Holly Tully. “Whether it's helping women achieve healthier weight or raising money for important disease research, the actions of our Brand Ambassadors are an extension of our commitment to making the world better."

The Brand Ambassadors, Amy Johnson, Jenna Beesley and Melissa Neil, participated in the 2016 Salt Lake City-based Real Women Real Results weight-loss program. By exercising, eating healthy and taking I-REMOVE, the women lost a combined 69 pounds during the 12-week program. They have maintained their weight loss by continuing to take I-REMOVE—a plant-based supplement clinically shown to deliver up to three times more weight loss than dieting alone.

The ladies have trained for the past few months in preparation for the race.

“I was so excited to be involved in Little Red Riding Hood this year,” said Johnson. “It gave me a goal to work toward, which helps me stay focused.”

Johnson credits I-REMOVE with helping her train. “It has helped me stay on-track with my food, which I have learned is truly the secret weapon to losing weight. We had so much fun working together and getting stronger to prepare for this race. It was a rewarding day!”

Visit i-remove.com to learn more about I-REMOVE.

About Zaluvida I-REMOVE was launched in the United States and Canada in 2016 by Zaluvida North America, headquartered in Salt Lake City, Utah. Zaluvida is a globally operating life science group that endeavors to rapidly develop solutions for the biggest challenges in healthcare. The company is led from its corporate offices in Switzerland and has branches in Germany, Wales, the Netherlands, the U.S., and Malaysia. By making use of unique bioactive compounds with pharma-grade efficacy, Zaluvida is a pioneer in therapies and technologies for obesity, antibiotic resistance and for the reduction of greenhouse gas emissions. Our team is united by the desire to use visionary biotech innovations to support as many people as possible in shaping a better future for themselves.  Visit www.zaluvida.com to learn more.

For Zaluvida media information, please contact the Zaluvida Press Office, [email protected].

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c74a2331-5b94-4867-bedd-6488decbaa37

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a70391c8-8ea3-487a-8a70-64ffeaad636d

Cami Rozanas
Zaluvida North America
801-703-8967
[email protected]